This brand name is authorized in Finland, France, Hong Kong SAR China, Spain, Turkey.
The drug NEPHROMAG contains one active pharmaceutical ingredient (API):
1
|
UNII
8NVY8268MY - MERTIATIDE
|
|
Technetium ⁹⁹ᵐTc mertiatide is a renal imaging agent for use in the diagnosis of congenital and acquired abnormalities, renal failure, urinary tract obstruction, and calculi in adults and pediatric patients. It is a diagnostic aid in providing renal function, split function, renal angiograms, and renogram curves for whole kidney and renal cortex. |
|
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V09CA03 | Technetium (99mTc) mertiatide | V Various → V09 Diagnostic radiopharmaceuticals → V09C Renal system → V09CA Technetium (99mTc) compounds |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 69466 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 186319 |
| FR | Base de données publique des médicaments | 60183061 |
| HK | Department of Health Drug Office | 59086 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8680967446022 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.